Kinetic Concepts’ V.A.C. Ulta therapy and Prevena incision management system were awarded Novation’s "Innovative Technology" designation, putting the devices in an elite category within the group purchasing organization’s catalog.
Novation, which represents close to 100,000 healthcare providers, awarded the designations at its annual Innovative Technology Expo, where products were evaluated and reviewed by hospital member-led councils.
The Ulta system combines KCI’s V.A.C. technology with V.A.C. VeraFlo instillation therapy to prevent infection in patients’ wounds. The Prevena incision management system uses negative pressure for surgical incision management for a variety of surgeries.
“The people of KCI are honored to be recognized for the significant clinical and financial benefit that KCI products and therapies bring to patients and hospital facilities alike," KCI Americas senior VP Jim Cunniff said in prepared remarks. "Our mission is simple: to provide transformative healing solutions to those who need it most. This designation affirms that our therapies – in this case, the V.A.C. Ulta Therapy System and our Prevena System – do indeed offer uniquely beneficial solutions to a broad spectrum of wounds, including the most challenging and complex cases."
The San Antonio-based wound care device maker recently landed FDA clearance for its V.A.C. Via., a portable negative-pressure wound care system featuring a diaphragm pump for faster draw down, longer battery life and a higher leak rate threshold.